50% off Premium Yearly
TG TherapeuticsTGTXBUYOct 20, 2020Stock price when the opinion was issued
As of Jun 12, 2026. Market Open.
Developing drugs for MS and blood cancers like leukemia. Exciting prospects; boasts promising clinical trial results, especially for their MS drug. Last month, they announced good phase 3 results for that drug which lifted share from the $30's to $50's. Cash flow is fine; they just said they've raised a lot of money.